Membranous nephropathy in chronic lymphocytic leukemia responsive to ibrutinib: A case report.
Leuk Res Rep
; 20: 100377, 2023.
Article
in En
| MEDLINE
| ID: mdl-37457553
ABSTRACT
Membranous nephropathy (MN) is an uncommon renal presentation in patients with chronic lymphocytic leukemia (CLL), and as such, there is no standard therapy for these patients. A few cases of MN in CLL have been described with varying success in MN treatment involving alkylating agents and fludarabine. Here we report the first case of MN in a patient with CLL treated with ibrutinib with complete renal response. This presentation underlines the importance of recognizing rare glomerular diseases that may occur with CLL and offers a new therapeutic avenue to the treatment of CLL-associated MN.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Leuk Res Rep
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos